B. Scott Segal to Neoplasms
This is a "connection" page, showing publications B. Scott Segal has written about Neoplasms.
Connection Strength
0.722
-
Mayor PC, Eng KH, Singel KL, Abrams SI, Odunsi K, Moysich KB, Fuleihan R, Garabedian E, Lugar P, Ochs HD, Bonilla FA, Buckley RH, Sullivan KE, Ballas ZK, Cunningham-Rundles C, Segal BH. Cancer in primary immunodeficiency diseases: Cancer incidence in the United States Immune Deficiency Network Registry. J Allergy Clin Immunol. 2018 03; 141(3):1028-1035.
Score: 0.348
-
Segal BH, Almyroudis NG, Battiwalla M, Herbrecht R, Perfect JR, Walsh TJ, Wingard JR. Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts. Clin Infect Dis. 2007 Feb 01; 44(3):402-9.
Score: 0.169
-
Almyroudis NG, Segal BH. Antibacterial prophylaxis in patients with cancer and neutropenia. N Engl J Med. 2006 Jan 05; 354(1):90-4; author reply 90-4.
Score: 0.158
-
Segal BM, Constantinescu CS, Raychaudhuri A, Kim L, Fidelus-Gort R, Kasper LH. Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study. Lancet Neurol. 2008 Sep; 7(9):796-804.
Score: 0.047